HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,957,144 | -68.4% | 21,848 | -70.0% | 0.00% | -66.7% |
| Q2 2023 | $6,194,190 | +12.7% | 72,753 | -29.8% | 0.01% | +20.0% |
| Q4 2021 | $5,494,000 | +342.4% | 103,583 | +890.4% | 0.01% | +42.9% |
| Q4 2020 | $1,242,000 | -83.6% | 10,459 | -88.0% | 0.01% | -85.7% |
| Q3 2020 | $7,583,000 | +122.0% | 86,911 | +127.9% | 0.05% | +104.2% |
| Q2 2020 | $3,415,000 | +728.9% | 38,132 | +964.2% | 0.02% | +700.0% |
| Q4 2019 | $412,000 | -97.8% | 3,583 | -97.6% | 0.00% | -98.0% |
| Q2 2019 | $18,335,000 | +109.7% | 152,363 | +52.4% | 0.15% | +268.3% |
| Q1 2019 | $8,744,000 | +4207.4% | 99,958 | +4324.9% | 0.04% | +1266.7% |
| Q2 2018 | $203,000 | -7.7% | 2,259 | -25.0% | 0.00% | -66.7% |
| Q1 2018 | $220,000 | -70.7% | 3,013 | -88.4% | 0.01% | +50.0% |
| Q2 2016 | $752,000 | -70.5% | 25,949 | -64.3% | 0.01% | -76.0% |
| Q1 2016 | $2,546,000 | – | 72,771 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |